Literature DB >> 22659372

Determination of permeability coefficients of ophthalmic drugs through different layers of porcine, rabbit and bovine eyes.

Christian Loch1, Simon Zakelj, Albin Kristl, Stefan Nagel, Rudolf Guthoff, Werner Weitschies, Anne Seidlitz.   

Abstract

To treat ophthalmic diseases like glaucoma or inflammatory disorders topically applied ophthalmic formulations such as eye drops are usually used. In addition, novel ophthalmic implants releasing drug substances locally into different parts of the eye are available today. In the work presented here, the permeability coefficients of selected drugs (ciprofloxacin hydrochloride, lidocaine hydrochloride, timolol maleate) for ophthalmic tissues were determined using side-by-side diffusion chambers (so-called Ussing chambers). Sclera, conjunctiva, cornea, choroidea-retina-complex and a complex of conjunctiva-sclera-choroidea-retina were excised from fresh porcine, rabbit and bovine eyes. In the porcine eye tissues the highest P(app) values were obtained for conjunctiva with the exception of lidocaine. Therefore, it can be estimated that a certain amount of drug diffuses or is transported through conjunctiva after application. The P(app) values for sclera were also higher than those for cornea and even more, the surface area of sclera which is available for drug absorption is much larger than that of cornea when applying an implant. The obtained permeability coefficients for sclera and conjunctiva indicate that the administration of periocular implants can be an alternative to topically applied formulations. The complexes of the tissues were a significantly (p<0.01) stronger barrier to the investigated substances than the separated tissues. Distinct differences in permeability coefficients between the investigated animal tissues were observed. Overall the highest P(app) values for all mounted tissues were obtained with the rabbit, followed by porcine and bovine eyes. Because of these distinct interspecies differences one must be very careful when selecting the proper animal model for the permeability experiments.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22659372     DOI: 10.1016/j.ejps.2012.05.007

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  18 in total

Review 1.  In vitro and ex vivo corneal penetration and absorption models.

Authors:  Priyanka Agarwal; Ilva D Rupenthal
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

2.  The characterization of the human nasal epithelial cell line RPMI 2650 under different culture conditions and their optimization for an appropriate in vitro nasal model.

Authors:  Mateja Erdani Kreft; Urška Dragin Jerman; Eva Lasič; Tea Lanišnik Rižner; Neli Hevir-Kene; Luka Peternel; Katja Kristan
Journal:  Pharm Res       Date:  2014-08-22       Impact factor: 4.200

3.  Physicochemical and Stability Evaluation of Topical Niosomal Encapsulating Fosinopril/γ-Cyclodextrin Complex for Ocular Delivery.

Authors:  Hay Marn Hnin; Einar Stefánsson; Thorsteinn Loftsson; Rathapon Asasutjarit; Dusadee Charnvanich; Phatsawee Jansook
Journal:  Pharmaceutics       Date:  2022-05-27       Impact factor: 6.525

4.  Nanosponge-Mediated Drug Delivery Lowers Intraocular Pressure.

Authors:  Wendi S Lambert; Brian J Carlson; Alice E van der Ende; Grace Shih; Julia N Dobish; David J Calkins; Eva Harth
Journal:  Transl Vis Sci Technol       Date:  2015-01-13       Impact factor: 3.283

5.  Atorvastatin-Eluting Contact Lenses: Effects of Molecular Imprinting and Sterilization on Drug Loading and Release.

Authors:  Ana F Pereira-da-Mota; María Vivero-Lopez; Ana Topete; Ana Paula Serro; Angel Concheiro; Carmen Alvarez-Lorenzo
Journal:  Pharmaceutics       Date:  2021-04-22       Impact factor: 6.321

6.  Enhancement in corneal permeability of riboflavin using calcium sequestering compounds.

Authors:  Peter W J Morrison; Vitaliy V Khutoryanskiy
Journal:  Int J Pharm       Date:  2014-06-10       Impact factor: 5.875

7.  Partitioning and Spatial Distribution of Drugs in Ocular Surface Tissues.

Authors:  Anusha Balla; Seppo Auriola; Angus C Grey; Nicholas J Demarais; Annika Valtari; Emma M Heikkinen; Elisa Toropainen; Arto Urtti; Kati-Sisko Vellonen; Marika Ruponen
Journal:  Pharmaceutics       Date:  2021-05-04       Impact factor: 6.321

8.  Permeability of the Retina and RPE-Choroid-Sclera to Three Ophthalmic Drugs and the Associated Factors.

Authors:  Hyeong Min Kim; Hyounkoo Han; Hye Kyoung Hong; Ji Hyun Park; Kyu Hyung Park; Hyuncheol Kim; Se Joon Woo
Journal:  Pharmaceutics       Date:  2021-05-04       Impact factor: 6.321

9.  Corneal absorption of a new riboflavin-nanostructured system for transepithelial collagen cross-linking.

Authors:  Katia M Bottos; Anselmo G Oliveira; Patrícia A Bersanetti; Regina F Nogueira; Acácio A S Lima-Filho; José A Cardillo; Paulo Schor; Wallace Chamon
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

10.  In Vitro and Ex Vivo Evaluation of Nepafenac-Based Cyclodextrin Microparticles for Treatment of Eye Inflammation.

Authors:  Blanca Lorenzo-Veiga; Patricia Diaz-Rodriguez; Carmen Alvarez-Lorenzo; Thorsteinn Loftsson; Hakon Hrafn Sigurdsson
Journal:  Nanomaterials (Basel)       Date:  2020-04-09       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.